|
Re: Key Dates Over the Next Four Months
|
7
|
Resverlogix Corp.
|
Jul 21, 2019 10:32AM
|
|
Re: Key Dates Over the Next Four Months
|
2
|
Resverlogix Corp.
|
Jul 21, 2019 09:30AM
|
|
Re: Key Dates Over the Next Four Months
|
8
|
Resverlogix Corp.
|
Jul 21, 2019 07:58AM
|
|
BETonMACE ClinicalTrials.gov update
|
8
|
Resverlogix Corp.
|
Jul 20, 2019 08:46AM
|
|
What's going on with the Phase 2 ZEN-3694 mCRPC trial?
|
6
|
Zenith Epigenetics
|
Jul 20, 2019 08:39AM
|
|
Re: Opportunity Knocks
|
2
|
Resverlogix Corp.
|
Jul 20, 2019 08:18AM
|
|
Re: Key Dates Over the Next Four Months
|
3
|
Resverlogix Corp.
|
Jul 20, 2019 08:11AM
|
|
Re: Zenith Shares
|
2
|
Resverlogix Corp.
|
Jul 19, 2019 06:41PM
|
|
Key Dates Over the Next Four Months
|
7
|
Resverlogix Corp.
|
Jul 19, 2019 06:27PM
|
|
Re: Opportunity Knocks
|
8
|
Resverlogix Corp.
|
Jul 19, 2019 10:48AM
|
|
Re: EASD 2019 Sept 16-20, 2019
|
2
|
Resverlogix Corp.
|
Jul 19, 2019 10:26AM
|
|
EASD 2019 Sept 16-20, 2019
|
4
|
Resverlogix Corp.
|
Jul 18, 2019 04:18PM
|
|
Re: 2019 Potential Events
|
4
|
Resverlogix Corp.
|
Jul 18, 2019 04:12PM
|
|
Bromodomains: a new target class for drug development
|
6
|
Resverlogix Corp.
|
Jul 16, 2019 07:18AM
|
|
Re: Resverlogix Announces Publication on Apabetalone in Clinical Epigenetics
|
4
|
Resverlogix Corp.
|
Jul 15, 2019 04:38PM
|
|
Re: Resverlogix Announces Publication on Apabetalone in Clinical Epigenetics
|
5
|
Resverlogix Corp.
|
Jul 15, 2019 03:58PM
|
|
Re: Resverlogix Announces Publication on Apabetalone in Clinical Epigenetics
|
1
|
Resverlogix Corp.
|
Jul 15, 2019 01:32PM
|
|
Re: Resverlogix Announces Publication on Apabetalone in Clinical Epigenetics
|
9
|
Resverlogix Corp.
|
Jul 15, 2019 11:50AM
|
|
Re: Resverlogix Announces Publication on Apabetalone in Clinical Epigenetics
|
1
|
Resverlogix Corp.
|
Jul 15, 2019 10:38AM
|
|
Re: Resverlogix Announces Publication on Apabetalone in Clinical Epigenetics
|
10
|
Resverlogix Corp.
|
Jul 15, 2019 10:25AM
|
